BURROUGHS WELLCOME TO RELAUNCH ANTIDEPRESSANT WELLBUTRIN IN MID-JULY AFTER ABORTED LAUNCH IN 1986; FDA-APPROVED LABELING INCLUDES DATA ON SEIZURE RISK

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".